Maternity Guidelines | WCH No. |
 Admission to Primary Birthing Unit | GLM0044 |
| Analgesia Prescribing After Child Birth | GLM0069 |
| Antenatal Corticosteroid Therapy | GLM0065 |
| Antenatal Ultrasound for Obstetric Indications: Recommended Scan Frequency | GLM0006 |
| Antenatal Obstetric Ultrasound: Indications for Doppler | GLM0059 |
|
Antepartum Haemorrhage | GLM0052 |
| Anti D - Use of Rh(D) Immunoglobulin in Unsensitised Rhesus Negative Women | GLM0047 |
Birth After Previous Caesarean Section | GLM0017 |
|
Bladder Care: Intrapartum and Postnatal | GLM0038 |
|
Breech Birth | GLM0048 |
|
Caesarean Section: Antibiotic Prophylaxis | GLM0050 |
|
Caesarean Section Assisted Deliveries in Theatre | GLM0040 |
| Cervical Insufficiency | GLM0055 |
Cholestasis - Obstetric | GLM0005 |
|
Cord Prolapse | GLM0039 |
|
Screening, Diagnosis and Management of Gestational Diabetes in New Zealand: A Clinical Practice Guideline | Ministry of Health |
|
Diabetes - Gestational | GLM0025 |
Diabetes - Type 1 | GLM0024 |
Diabetes - Type 2 | GLM0023 |
| Diabetic Ketoacidosis Management in Pregnancy | GLM0061 |
| Insulin Infusion following Betamethasone Injections for Women with Diabetes in Pregnancy (C260117) | Ref.6466 |
|
Dural Puncture Accidental | GLM0008 |
Epidural Analgesia in Labour
| GLM0007 |
External Cephalic Version | GLM0016 |
Fetal Heart Monitoring | GLM0010 |
| Fetal Movements | GLM0045 |
| Group-B Streptococcus - Management and Prophylactic Antibiotics in Labour | GLM0032 |
Herpes in pregnancy | 17th ed. 2017 |
|
Histological Examination of the Placenta | GLM0031 |
HIV Infected Women During Pregnancy and Childbirth | GLM0033 |
|
Hypoglycaemia of the Newborn | GLM0056 |
|
Induction of Labour under review but Misoprostol updated Nov 2020 | GLM0035 |
| Oral Misoprostol Induction of Labour | |
| Induction of Labour Patient Information | Ref.2400320 |
| Misoprostol Induction of Labour Pathway | Ref.2407461 |
|
In-Utero Transfer Between Hospitals | Ref.7208 |
Magnesium Sulphate for Neuroprotection in Preterm-Births | GLM0041 |
| Management of Suspected Small for Gestational Age Singleton Pregnancies After 34 Weeks Gestation | NZ Maternal Fetal Medicine Network |
Maternal Blood Optimisation Pathways (MBOP) Guideline and Practice Improvement Strategy
(also see MBOP section below) | GLM0070 |
|
Maternal Mental Health Pathway: Referral and Support Services in Canterbury | Ref.2406554 |
 Newborn Screening Guidelines | NSU website |
| Notifiable Diseases | HealthPathways |
| Observation of Mother and Baby in the Immediate Postnatal Period: Consensus Statements Guiding Practice | Ref.6537 |
|
Opioid Use in Labour | GLM0053 |
 Periviability Consensus Statement | Starship |
|
Placenta Praevia and Placenta Accreta | GLM0002 |
|
Polyhydramnios | GLM0054 |
Postpartum Haemorrhage | GLM0021 |
Pre-Eclampsia | GLM0003 |
Pre-Labour Rupture of Membranes at Term | GLM0043 |
Preterm Labour/Birth | GLM0027 |
Periviability Consensus Statement Checklist: Antenatal care plan if at high risk of birth at 23 weeks to 24 weeks + 6 days Parent Information: Shared decision making at 23 weeks and 24 weeks gestation | Starship Ref.2406246 Ref.2406427 |
Preterm Pre-Labour Rupture of Membranes | GLM0028 |
|
Progress in Labour | GLM0062 |
| Puerperal Sepsis | GLG0017 |
| Referral/Transfer to Christchurch Women's Hospital from West Coast | GLM0063 |
Registrar Supervision | GLM0019 |
| Maternity Referrals | HealthPathways |
| Remifentanil Patient Controlled Analgesia for Labour | GLM0042 |
| Sexually Transmitted Infection Guidelines | Just the Facts website |
Shoulder Dystocia | GLM0011 |
| Substance Abuse in Pregnancy | GLM0067 |
| SUDI Prevention Safe Infant Sleep Policy | Ref.2404926 |
| Swab and Instrument Counting Outside Theatre in the Maternity Setting | GLM0068 |
| Syphilis in Pregnancy | NZSHS |
|
Tears: Third and Fourth Degree | GLM0036 |
| Treating adults who decline blood products (including Jehovah's Witnesses) | Red book |
| Twin Pregnancy and Birth | GLM0064 |
|
Venous Thromboembolism VTE in Postpartum | GLM0046/A |
Water for Birth and Labour | GLM0037 |